Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Thumb Muscle Activation During First Dorsal Interosseous Activities of Daily Living in Thumb Base Osteoarthritis

21 juin 2026 mis à jour par: carmen menaya fernandez, University of Malaga

A Between-Group Comparison of First Dorsal Interosseous and Abductor Pollicis Longus Muscle Activation During First Dorsal Interosseous Activities of Daily Living in Individuals With and Without Thumb Base Osteoarthritis

The aim of this study is to investigate whether there are differences in muscle activation of the First Dorsal Interosseous (FDI) and the Abductor Pollicis Longus (APL) between individuals with and without trapeziometacarpal osteoarthritis (TMC OA) of the thumb during the performance of six activities of daily living (ADLs).

The FDI has been defined as a key stabilizer of the TMC joint of the thumb. However, the literature reports limited information on FDI and APL activation during ADLs. TMC OA of the thumb can cause pain, decreased thumb strength, impaired hand function, and difficulty performing ADLs. Understanding muscle activation patterns during these activities is essential to comprehend how this condition affects hand function and to guide more specific and effective rehabilitation strategies.

Participants will perform six ADLs: turning a key to open, turning a key to close, picking up a coin, writing, squeezing a tube of toothpaste, and holding a glass of water. Muscle activity will be recorded using surface electromyography (sEMG) during all tasks.

Adults aged 30 years and older, both men and women, with TMC osteoarthritis and healthy controls without osteoarthritis will be invited to participate.

Researchers will measure the activation patterns of the FDI and APL muscles during the ADLs, with the aim of identifying differences between both groups and providing evidence to guide the rehabilitation of patients with thumb base osteoarthritis.

Aperçu de l'étude

Statut

Pas encore de recrutement

Description détaillée

Trapeziometacarpal osteoarthritis (OA TMC) of the thumb is a chronic and progressive degenerative disease characterized by loss of articular cartilage, subchondral sclerosis, capsuloligamentous laxity, and osteophyte formation in the first metacarpal. Patients typically present with pain and muscle weakness, which impair hand function and limit activities of daily living (ADLs), resulting in a considerable personal and social burden, including reduced quality of life and work disability. Previous studies have highlighted the clinical importance of thumb TMC joint stabilizers. Research has demonstrated that the first dorsal interosseous (FDI) functions as the main stabilizer of the TMC joint, whereas the abductor pollicis longus (APL) acts as a primary destabilizer. These findings suggest that rehabilitation programs should focus on strengthening the FDI to improve joint stability. However, despite the clinical importance of targeting these muscles, the literature reports limited information on how the FDI and APL behave during activities of daily living.

The aim of this study is to investigate whether there are differences in muscle activation of the FDI and APL between individuals with and without thumb OA TMC during the performance of six activities of daily living, in order to inform rehabilitation strategies. Adequate rehabilitation is essential for maintaining muscle function, slowing the progression of joint degeneration, and improving hand performance, yet it remains unclear how these muscles are engaged during functional daily tasks.

This is a cross-sectional observational comparative study with both within-subject and between-group analyses. The study includes two groups: adults aged 30 years and older, both men and women, with a clinical diagnosis of OA TMC and healthy controls without musculoskeletal or neurological disorders affecting the hand. Exclusion criteria include sensory disturbances such as numbness or tingling, cardiac pacemaker implantation, upper limb entrapment neuropathies or cervical radiculopathy, neuromuscular diseases, systemic conditions including diabetes or hypothyroidism, history of cancer, rheumatoid arthritis, anticoagulation therapy, chemotherapy, exposure to neurotoxins, or recent upper limb trauma or surgery.

Surface electromyography (sEMG) is used to record muscle activity of the FDI and APL. Skin is prepared by shaving if necessary and cleaning with alcohol to reduce impedance and ensure optimal adherence of surface electrodes. Bipolar surface electrodes with a diameter of 20 millimeters and an inter-electrode distance of 20 millimeters are placed according to SENIAM guidelines. For the FDI, electrodes are positioned over the dorsal belly of the muscle aligned with fiber direction, with one electrode in the distal ulnar region between the first and second metacarpals. For the APL, electrodes are placed approximately five centimeters distal to the wrist, medial to the radius, longitudinally aligned and transversely away from adjacent muscles. Electrode placement is verified by palpation and selective activation tasks.

Participants perform six standardized tasks simulating ADLs: turning a key toward the ulnar side, turning a key toward the radial side, picking up a coin, writing a word with a pen, squeezing a full tube of toothpaste, and holding a glass of water while performing a drinking gesture. Each task is performed in three consecutive three-second isometric repetitions with a thirty-second rest between repetitions to minimize fatigue.

It is hypothesized that individuals with thumb TMC osteoarthritis will demonstrate altered activation patterns of the FDI and APL compared with healthy controls, and that specific functional tasks will elicit greater FDI activation, supporting targeted interventions to enhance joint stability and hand function in patients with thumb base osteoarthritis.

Type d'étude

Observationnel

Inscription (Estimé)

50

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: CARMEN MENAYA FERNANDEZ, Doctoral Student
  • Numéro de téléphone: +34658424375
  • E-mail: cmenayaf@gmail.com

Lieux d'étude

    • Málaga
      • Málaga, Málaga, Espagne, 29071
        • Universidad de Málaga

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Oui

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

The study population will include adults aged 30 years and older, both men and women, divided into two groups. The first group will consist of individuals with a clinical diagnosis of thumb trapeziometacarpal osteoarthritis, and the second group will consist of healthy controls without musculoskeletal or neurological disorders affecting the hand.

La description

Inclusion criteria for the TMC OA group:

- Clinical diagnosis of thumb TMC osteoarthritis.

Inclusion criteria for the healthy group:

- Participants with no history of musculoskeletal or neurological disorders affecting the dominant hand were included.

Exclusion Criteria :

  • Presence of numbness, tingling, or other sensory disturbances
  • Cardiac pacemaker implantation
  • Upper limb entrapment neuropathy or cervical radiculopathy
  • History of neuromuscular disease, polyneuropathy, or plexopathy
  • Systemic diseases such as diabetes, hypothyroidism, or chronic liver or kidney disease
  • History of cancer, rheumatoid arthritis, active anticoagulation therapy, chemotherapy, or exposure to neurotoxins
  • Recent upper limb soft tissue or bone injury (trauma, fracture, or surgery of the arm or neck).

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Surface electromyographic amplitude of the First Dorsal Interosseous muscle.
Délai: Day 1
Mean surface electromyographic amplitude of the First Dorsal Interosseous muscle recorded during each of the 6 activities of daily living.
Day 1
Surface electromyographic amplitude of the Abductor Pollicis Longus muscle
Délai: Day 1
Mean surface electromyographic amplitude of the Abductor Pollicis Longus muscle recorded during each of the 6 activities of daily living
Day 1

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

5 juin 2026

Achèvement primaire (Estimé)

30 août 2026

Achèvement de l'étude (Estimé)

30 août 2026

Dates d'inscription aux études

Première soumission

29 mai 2026

Première soumission répondant aux critères de contrôle qualité

21 juin 2026

Première publication (Réel)

25 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

25 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

21 juin 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner